Graham Maw

COO at EligoChem

Graham is a highly experienced and motivated drug discovery scientist and senior leader with over 20 years of experience gained from working as an inventive and creative medicinal chemist in a number of therapeutic areas. He has led discipline and matrix teams of up to 50 scientists and has successfully run drug discovery programmes from idea (hit-generation) to first-in-human lcandidate selection and R1).

Graham joined Pfizer in 1991, gaining extensive experience of medicinal chemistry design and applying this to the discovery of novel, small-molecule drug candidates against a range of biological targets leading to, for example, enzyme inhibitors, GPCR agonists, GPCR antagonists and ion-channel modulators voltage and ligand-gated).

Graham has considerable scientific leadership experience and has previously held the senior positions of Head of Pain Chemistry, Head of Genitourinary, Allergy and Respiratory Chemistry and Head of Exploratory Chemistry, New Opportunities Unit at Pfizer and was responsible for defining the Medicinal Chemistry strategy for large teams of talented scientists.

Peers

View in org chart

Timeline

  • COO

    Current role